Product Code: BIO188B
Highlights:
The global organ-on-a-chip market should reach $183.4 million by 2026 from $32.0 million in 2021 at a compound annual growth rate (CAGR) of 41.8% for the forecast period of 2021 to 2026.
The lung segment of global organ-on-a-chip market is expected to grow from $8.0 million in 2021 to $47.9 million in 2026 at a CAGR of 43.1% for the forecast period of 2021 to 2026.
The heart segment of global organ-on-a-chip market is expected to grow from $7.4 million in 2021 to $43.9 million in 2026 at a CAGR of 42.7% for the forecast period of 2021 to 2026.
Report Scope:
The scope of this report covers various types of products available in the organ-on-a-chip market and potential application sectors in various industries. The organ-on-a-chip market is broken down into various segments. Revenue forecasts from 2019 to 2026 are given for each type, application, offering and end user. Revenue generated from the installation and maintenance of instruments has been excluded from the report. The application segment is characterized by various types, including drug discovery and development, toxicological research, and physiological model development, and by end-use industry, including academic and research institutes, pharmaceutical and biotechnology companies, cosmetics industry and other end users. By type market is segmented to liver, lung, kidney, heart and others. The report also focuses on regional segmentation of the market.
Further, it explains the major drivers and regional dynamics of the global market and current trends within the industry. It also includes information about the industry structure and competitive landscape as well as the impact of COVID-19 on the market. The report includes detailed profiles of the major players in the global organ-on-a-chip market.
Report Includes:
- 55 data tables and 29 additional tables
- An up-to-date review and analysis of the global markets for organ-on-a-chip within the biotech industry
- Analyses of the global market trends, with data from 2019 to 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Information on multi-channel 3-D microfluidic cell culture chip, and discussion of their ability to imitate human microenvironment in vitro
- Evaluation and forecast the global organ-on-a-chip market size, and corresponding market share analysis by technology offering, organ type, application, end-user vertical and region
- Discussion on how organ-on-a-chip is emerging as a priority testing alternative which is replacing animals in life science research, toxicology testing and drug development studies
- Review of potential applications in pharmaceutical and life science research sectors, including preclinical drugs testing, drug screening, personalized medicine, phenotypic screening, lead optimization and disease modelling
- Insights into the recent industry structure including the government programs and policies in support of organ-on-a-chip and coverage of revised laws involving animal testing
- Review of patent grants for innovations in organ-on-a-chip technology across each major category
- Descriptive company profiles of the leading global players, including 4Dcell, BiomimX, Emulate Inc., Kirkstall Ltd., Nortis and TissUse GmbH
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- What's New in This Update?
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- BCC Custom Research
- Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
- Introduction
- Developments in Drug Discovery
- 1950-1970
- 1970-1990
- 1990-2010
- 2010 to the Present
- Market Potential
- Strategic Initiatives
- Regulatory Framework
- U.S.
- European Union
- China
- Japan
Chapter 4 Market Dynamics
- Factors Affecting the Organ-on-a-Chip Market
- Market Drivers
- Increasing Incidence of Chronic Diseases
- Rising Demand for a Way to Enhance the Effectiveness of Clinical Trials
- Increasing Investments for Drug Research and Development
- Increasing Demand for Personalized Medicine
- Market Restraints
- Lack of Standardization
Chapter 5 Impact of COVID-19
- Introduction
- Outbreak Origins
- Symptoms of COVID-19
- Progression of COVID-19
- Incubation Period
- Epidemiology
- Collaboration Between Organizations and Governments
- Spread of Disease
- Impact of COVID-19 on the Organ-on-a-Chip Market
Chapter 6 Global Organ-on-a-Chip Market by Type
- Liver
- Liver-on-a-Chip Classifications Depending on Their Principal Actions
- Heart
- Kidney
- Lung
- Other Organs
Chapter 7 Global Organ-on-a-Chip Market by End User
- Biotechnology and Pharmaceutical Companies
- Cosmetics Industry
- Academic and Research Institutes
- Increasing R&D Spending
- Other End Users
Chapter 8 Global Organ-on-a-Chip Market by Offering
Chapter 9 Global Organ-on-a-Chip Market by Application
- Drug Discovery and Development
- Toxicological Research
- Physiological Model Development
Chapter 10 Global Organ-on-a-Chip Market by Region
- North America
- U.S.
- Canada
- Europe
- U.K.
- France
- Germany
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of the World
Chapter 11 Industry Structure
- Raw Material Suppliers
- Quality and Technology
- Terms and Conditions
- Cost-Effective Components
- Manufacturers
- Distributors
- End Users of Consumables
- Competitive Analysis
- Patent Landscape
- Patent Review by Year
- Patent Review by Country
Chapter 12 Company Profiles
- 4DCELL
- AXOSIM
- BEONCHIP
- BIOMIMX
- BIOIVT
- CHERRY BIOTECH
- CN BIO
- ELVEFLOW
- EMULATE INC.
- FLUIGENT
- HESPEROS INC.
- HUREL CORP.
- INSPHERO
- KIRKSTALL
- MESOBIO TECH
- MICRONIT
- MIMETAS
- NORTIS
- SYNVIVO
- TARA BIOSYSTEMS INC.
- TISSUSE GMBH